Annals
Established in 1927 by the American College of Physicians
:
Advanced search
box Article
 arrow  Table of Contents                
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
Articles in PubMed by Author:
  arrow  Zelicoff, A. P.
space
 arrow  Related Articles in PubMed
space
 arrow  PubMed Citation
space
 arrow  PubMed
space

LETTER

More on the Most Terrible of the Ministers of Death

right arrow Alan P. Zelicoff, MD

1 May 1998 | Volume 128 Issue 9 | Pages 784-785


TO THE EDITOR:

Barquet and Domingo [1] present an enthralling history of the smallpox virus but end their article with a regrettably incomplete summary of the recent scientific debate over the destruction of variola. Since the time of the most recent stay of execution of the virus in early 1996, some of the rich scientific and medical value of variola has come to light. Indeed, in the past few years, tantalizing bits of understanding of the unique propensity of the virus to induce immune tolerance or immunosuppression by way of cytokine inhibition [2] and of the structure-function relations of the genome [3] have been determined. That these properties have now been related to protein products of the virus is perhaps unsurprising given Barquet and Domingo's observation that many strains of the virus cause disease with extraordinarily high penetrance in a given population. However, the previously elusive mechanisms of action, including interference with MHC-restricted antigen presentation, strongly suggest novel models of immune modulation of relevance to other immunosuppressive agents, and the potential for exploitation for important clinical application, such as organ transplantation [4]. Ironically, this "most terrible of the ministers of death" may hold the key to selective inhibition of primary immune system responses, advancing us toward immunosuppressive regimens far less toxic to patients.

Proponents of destruction state that cloning of variola provides an adequate store of genetic material for later study. Although cell biologists have learned much from atomizing their targets, all virologists know that smashing a watch to bits does present a daunting obstacle to learning all of its integrated functionality. Immune system manipulation using the hitherto-disparaged virus requires retention of the entirety of the genome [5] or of pieces that can easily be fully reconstituted. Elimination of the virus is not only political folly; recent literature demonstrates that squandering this immensely valuable resource is scientifically imprudent at this stage of our knowledge.


Author and Article Information
space
up arrowTop
dotAuthor & Article Info
down arrowReferences

Sandia National Laboratories; Albuquerque, NM 87185


References
space
up arrowTop
up arrowAuthor & Article Info
dotReferences

1. Barquet N, Domingo P. Smallpox: the triumph over the most terrible of the ministers of death. Ann Intern Med. 1997; 127:635-42.

2. Smith TD, Smolak PJ, Friend D, Hagen H, Gerhart M, Park L, et al. Poxvirus genomes encode a secreted, soluble protein that preferentially inhibits ß chemokine activity yet lacks sequence homology to known chemokine receptors. Virology. 1997; 236:316-27.

3. Shchelkunov SN, Totmenin AV, Babkin IV, Safronov PF, Gutorov VV, Pozdnyakov SG, et al. [Study of the structure activity organization of smallpox virus genome. V. Sequencing and analysis of the left-hand terminus of the India-1967 strain.] Mol Biol (Mosk). 1996; 30:595-612.

4. Sandakhchiev LS. The Scientist. 1993; 7:9.

5. Lederberg J. Future studies of pathogens depend on conserving microbes. The Scientist. 1997; 11:8.

About Letters
space

The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:

•Include no more than 300 words of text, three authors, and five references

•Type with double-spacing

•Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.

Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.

Annals welcomes electronically submitted letters.





box Article
 arrow  Table of Contents                
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
Articles in PubMed by Author:
  arrow  Zelicoff, A. P.
space
 arrow  Related Articles in PubMed
space
 arrow  PubMed Citation
space
 arrow  PubMed
space


 Home | Current Issue | Past Issues | In the Clinic | ACP Journal Club | CME | Collections | Audio/Video | Mobile | Subscribe | Tools | Help | ACP Online